Literature DB >> 17534699

Effect of hepatocyte growth factor (HGF) on the level of Survivin & XIAP expression in several human cancer cell lines, after treating with DNA damaging agent.

Kianoosh Keyhanian1, Rosita Edalat, Akbar Oghalaei, Nayere Askary, Arghavan Golshani, Mansour Salehi, Ramin Sarrami-Forooshani, Mohammad Ali Shokrgozar.   

Abstract

Hepatocyte growth factor (HGF) has opposite biological activities in regulating apoptosis, also underlying molecular mechanisms are not clearly defined. We investigated HGF ability to inhibit cell death, which was induced by Doxorubicin, a DNA damaging agent. Also Survivin and XIAP mRNA levels were compared in HGF treated and non-treated cells. Cell proliferation and death were assessed using MTT assay and dye exclusion tests. Quantitative real-time PCR was used to evaluate Survivin and XIAP expression levels after treatment with HGF. ELISA was performed to quantify HGF secretion in the selected cancer cell lines media. HGF appeared to have inhibitory effect on Doxorubicin induced cell death in all of the studied cell lines. It had minimal effect on XAIP and Survivin expression levels in MRC-5, MOLT-4 and AGS cell lines; except for XIAP expression level in AGS cell line, which was increased substantially after treatment. Surprisingly, in KG-1 cell line, XIAP and Survivin expression levels were significantly reduced after HGF treatment. Although several members of IAP gene family are reported to play role in HGF mediated cytoprotective pathway, we showed that XIAP and Survivin do not seem to be involved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17534699     DOI: 10.1007/s11010-007-9500-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  27 in total

Review 1.  Caspase pathways, neuronal apoptosis, and CNS injury.

Authors:  B A Eldadah; A I Faden
Journal:  J Neurotrauma       Date:  2000-10       Impact factor: 5.269

Review 2.  New insights into the role of nuclear factor-kappaB in cell growth regulation.

Authors:  F Chen; V Castranova; X Shi
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 3.  XIAP: apoptotic brake and promising therapeutic target.

Authors:  M Holcik; H Gibson; R G Korneluk
Journal:  Apoptosis       Date:  2001-08       Impact factor: 4.677

Review 4.  Hepatocyte growth factor: from diagnosis to clinical applications.

Authors:  Hiroshi Funakoshi; Toshikazu Nakamura
Journal:  Clin Chim Acta       Date:  2003-01       Impact factor: 3.786

5.  X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling.

Authors:  Hiroya Takeuchi; Joseph Kim; Akihide Fujimoto; Naoyuki Umetani; Takuji Mori; Anton Bilchik; Rod Turner; Andy Tran; Christine Kuo; Dave S B Hoon
Journal:  Clin Cancer Res       Date:  2005-11-01       Impact factor: 12.531

6.  Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.

Authors:  Lorraine Tracey; Alberto Pérez-Rosado; Maria Jesús Artiga; Francisca I Camacho; Antonia Rodríguez; Nerea Martínez; Elena Ruiz-Ballesteros; Manuela Mollejo; Beatriz Martinez; Marta Cuadros; Juan F Garcia; Mark Lawler; Miguel A Piris
Journal:  J Pathol       Date:  2005-06       Impact factor: 7.996

7.  Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection.

Authors:  Saijun Fan; Min Gao; Qinghui Meng; John J Laterra; Marc H Symons; Sal Coniglio; Richard G Pestell; Itzhak D Goldberg; Eliot M Rosen
Journal:  Oncogene       Date:  2005-03-03       Impact factor: 9.867

8.  IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition.

Authors:  M Germana Sanna; Jean da Silva Correia; Odile Ducrey; Jongdae Lee; Ken Nomoto; Nicolas Schrantz; Quinn L Deveraux; Richard J Ulevitch
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

Review 9.  Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.

Authors:  Wen G Jiang; Tracey A Martin; Christian Parr; Gaynor Davies; Kunio Matsumoto; Toshikazu Nakamura
Journal:  Crit Rev Oncol Hematol       Date:  2005-01       Impact factor: 6.312

Review 10.  The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis.

Authors:  R Zarnegar; G K Michalopoulos
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

View more
  1 in total

1.  Met kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survival.

Authors:  Gideon Y Stein; Nir Yosef; Hadar Reichman; Judith Horev; Adi Laser-Azogui; Angelique Berens; James Resau; Eytan Ruppin; Roded Sharan; Ilan Tsarfaty
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.